Form 4: Abeona Therapeutics Director Faith L. Charles Acquires Shares
SEC Form 4
Director Faith L. Charles acquired 23,611 shares of Abeona Therapeutics Inc. on July 8, 2024.
Summary
- On July 8, 2024, Faith L. Charles, a director of Abeona Therapeutics Inc., acquired 23,611 shares of common stock.
- The shares were acquired at a price of $0.00.
- Following the transaction, Charles directly owns 101,934 shares of Abeona Therapeutics Inc.
- The restricted stock will vest on July 8, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director's share acquisition. The acquisition itself could be seen as mildly positive, but the document is primarily informational.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who trade in their company's stock. It provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of transaction: Faith L. Charles acquired 23,611 shares of Abeona Therapeutics Inc. |
| 07/08/2025 | Vesting date for the restricted stock. |
| 07/09/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.